Baumer SA
Baumer SA maintains a conservative capital structure with a debt-to-equity ratio of 0.13, indicating a low reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 2.86, suggesting it can cover short-term obligations but with limited excess capacity. However, the company's free cash flow is negative at -506,000 BRL, and its net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Baumer SA's return on equity (ROE) is 2.7%, and its return on assets (ROA) is 1.58%. These figures are below the typical thresholds for high-performing healthcare equipment firms, indicating that the company is not generating strong returns relative to its equity and asset base. The operating margin, calculated as operating income of 4,264,000 BRL on revenue of 36,320,000 BRL, is 11.74%, which is in line with the industry's median but not exceptional. The company's revenue is not segmented by geographic region or product line in the available data, so it is not possible to assess geographic or segment concentration risk. However, the lack of segmentation data suggests that the company may have a relatively undiversified revenue base, which could expose it to regional or product-specific risks. Looking ahead, the company's growth trajectory is not clearly defined in the available data. The absence of specific revenue growth projections or historical growth rates makes it difficult to assess the company's future performance. The capital expenditure of -2,649,000 BRL indicates that the company is investing in its operations, but the negative free cash flow suggests that these investments are not yet generating positive cash returns. The risk assessment for Baumer SA highlights a medium liquidity risk and a low dilution risk. The company's shares outstanding are the same for both basic and diluted shares, indicating no imminent threat of share dilution. However, the negative free cash flow and the negative net cash position after debt suggest that the company may need to raise additional capital in the near term, which could introduce new risks. There are no recent events or filings mentioned in the available data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests that the company may not be actively communicating with investors or disclosing material developments.
Business. Baumer SA is a medical equipment and supplies company that generates revenue through the distribution and sale of healthcare products and services.
Classification. Baumer SA is classified in the industry "Medical Equipment, Supplies & Distribution" under the Healthcare Services & Equipment business sector, with a confidence level of 0.92.
- Baumer SA has a conservative capital structure with a low debt-to-equity ratio of 0.13.
- The company's return on equity (2.7%) and return on assets (1.58%) are below typical thresholds for high-performing healthcare equipment firms.
- The company's liquidity position is characterized as medium risk, with a current ratio of 2.86.
- The company's free cash flow is negative at -506,000 BRL, and its net cash position is negative after subtracting total debt.
- The company's growth trajectory is not clearly defined in the available data.
- The company has a low dilution risk, with no imminent threat of share dilution.
- --
- # RATIONALES
- Net cash is negative after subtracting total debt.